Titan Medical Inc (TMDIF)

[66Mustang]

Dice, my understanding is that Oppenheimer puts out an estimate as to what they think the stock price will be at some point; it has virtually nothing to do with things like the technology or future market opportunity, at least not until the "future market opportunity" is very close at hand, such as expecting the FDA to say "Go" with a few weeks. Otherwise, it's just a prediction for PPS, and they do need to factor in things like historical short percentages as considerations.

For an acquisition, the valuation is based on a more in-depth analysis of all things of value, including patent portfolio (not just individual patents but the portfolio as a whole and how well it encompasses a variety of opportunities to suppress like technologies on competitors' products), plus short-term and long-term market opportunity (which could include subsequent licensing of more patented technologies), development pipeline/projects, etc. And I believe someone said that three independent evaluations are typically conducted for such an acquisition target. Supposedly PPS and Market Cap have nothing at all to do with this. As I understand it (never been through it myself tho...)

Anyone with experience in this care to chime in?


Message in reply to:
I’d say extremely low probability of my scenario. But, I cant see how an acquirer would justify anything north of $10 a share by June unless the sp jumps between now and then. The recent $4 price target kind of puts a ceiling on things.